Literature DB >> 9784104

Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase.

D J Augeri1, S J O'Connor, D Janowick, B Szczepankiewicz, G Sullivan, J Larsen, D Kalvin, J Cohen, E Devine, H Zhang, S Cherian, B Saeed, S C Ng, S Rosenberg.   

Abstract

Potent and selective non-thiol-containing inhibitors of protein farnesyltransferase are described. FTI-276 (1) was transformed into pyridyl ether analogue 19. The potency of pyridyl ether 19 was improved by modification of the biphenyl core to that of an o-tolyl substituted biphenyl core to give 29. In addition to 0.4 nM in vitro potency, 29 displayed 350 nM potency in whole cells as the parent carboxylic acid. The o-tolyl biphenyl core dramatically and unexpectedly enhanced the potency of other compounds as exemplified by 46, 47, 48, and 49.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784104     DOI: 10.1021/jm980298s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Radioiodinated O(6)-Benzylguanine derivatives containing an azido function.

Authors:  Ganesan Vaidyanathan; Benjamin White; Donna J Affleck; Darryl McDougald; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2010-10-27       Impact factor: 2.408

2.  Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.

Authors:  Joshua D Ochocki; Mark D Distefano
Journal:  Medchemcomm       Date:  2013-03       Impact factor: 3.597

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.